PPMD Community

[Upcoming Webinar] Understanding the FDA Approval of EMFLAZA™ (deflazacort)

Event Details

[Upcoming Webinar] Understanding the FDA Approval of EMFLAZA™ (deflazacort)

Time: February 10, 2017 from 12pm to 1pm
Location: Online Webinar - Eastern Time Zone
Website or Map: https://www.readytalk.com/join
Phone: 1.866.740.1260 -- Access code: 9449985
Event Type: webinar
Organized By: PPMD
Latest Activity: Feb 9

Export to Outlook or iCal (.ics)

Event Description

Friday, February 10th at 12 PM EST / 9 AM PST

We are pleased to learn that the FDA has approved EMFLAZA (deflazacort). The FDA’s approval of EMFLAZA provides options for families when making decisions about care with their providers. During this webinar, the Marathon team will provide information about EMFLAZA’s FDA-approved label, patient support services, and access to this medication.

Speakers:

  • Pat Furlong, PPMD Founding President & CEO
  • Jeff Aronin, Marathon Pharmaceuticals CEO
  • Dr. Tim Cunniff, Marathon Pharmaceuticals, EVP of Research & Development
  • Eric Messner, Marathon Pharmaceuticals, VP of Sales & Marketing
  • Greg Wujek, Marathon Pharmaceuticals, VP of Market Access

To Participate:

  1. Visit ReadyTalk.com and use access code 9449985. (Be sure to test your computer beforehand)
  2. Audio Dial-In Information:
    • U.S. & Canada: Dial 1.866.740.1260 and use the Access Code 9449985
    • Outside the U.S. and Canada: Lookup your number

 

This webinar is hosted by PPMD. For those who cannot make the call, it will be recorded and made available on the PPMD website until Friday, February 24th, as directed by Marathon. As always, it is best to talk to your physician regarding your medical care.

 

Comment Wall

Comment

RSVP for [Upcoming Webinar] Understanding the FDA Approval of EMFLAZA™ (deflazacort) to add comments!

Join PPMD Community

Attending (2)

© 2017   Created by PPMD.   Powered by

Badges  |  Report an Issue  |  Privacy Policy  |  Terms of Service